Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
AHCO 
Adapthealth Corp (AHCO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/01/2025: AHCO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $13.25
1 Year Target Price $13.25
| 5 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -76.2% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.32B USD | Price to earnings Ratio 17.73 | 1Y Target Price 13.25 |
Price to earnings Ratio 17.73 | 1Y Target Price 13.25 | ||
Volume (30-day avg) 8 | Beta 1.78 | 52 Weeks Range 7.11 - 11.63 | Updated Date 12/2/2025 |
52 Weeks Range 7.11 - 11.63 | Updated Date 12/2/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.55 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-11-04 | When - | Estimate 0.24 | Actual 0.16 |
Profitability
Profit Margin 2.53% | Operating Margin (TTM) 8.18% |
Management Effectiveness
Return on Assets (TTM) 3.64% | Return on Equity (TTM) 5.52% |
Valuation
Trailing PE 17.73 | Forward PE 8.38 | Enterprise Value 3143970256 | Price to Sales(TTM) 0.41 |
Enterprise Value 3143970256 | Price to Sales(TTM) 0.41 | ||
Enterprise Value to Revenue 0.97 | Enterprise Value to EBITDA 4.92 | Shares Outstanding 135424334 | Shares Floating 88013966 |
Shares Outstanding 135424334 | Shares Floating 88013966 | ||
Percent Insiders 8.13 | Percent Institutions 104.04 |
Upturn AI SWOT
Adapthealth Corp
Company Overview
History and Background
Adapthealth Corp. was formed through the merger of several durable medical equipment (DME) providers. It officially came into being in 2012. Through acquisitions and organic growth, it has become a leading provider of home medical equipment and services, focused on chronic disease management.
Core Business Areas
- Sleep Therapy Equipment: Supplies CPAP and BiPAP machines, masks, and related accessories for the treatment of sleep apnea. Includes ongoing resupply programs.
- Home Medical Equipment (HME): Offers a range of medical equipment, including wheelchairs, walkers, and other mobility aids, as well as respiratory equipment and other home healthcare products.
- Diabetes Care: Provides continuous glucose monitors (CGMs) and related supplies for patients with diabetes. The company ships CGMs directly to patients' homes, simplifying access to essential diabetes management tools.
Leadership and Structure
Luke McGee serves as Chief Executive Officer. The company operates with a management team overseeing various functional areas, including operations, finance, and sales. The Board of Directors provides governance and strategic oversight.
Top Products and Market Share
Key Offerings
- CPAP/BiPAP Machines and Supplies: These devices are central to treating sleep apnea. The market is competitive, with companies like ResMed (RMD) and Philips (PHG) (Philips is experiencing significant market share loss due to product recalls) being major competitors. Market share data is not readily available, but Adapthealth is a significant player in the resupply market.
- Continuous Glucose Monitors (CGMs): CGMs help diabetes patients track blood glucose levels in real-time. Competitors include Dexcom (DXCM) and Abbott (ABT). Market share data specific to Adapthealth's CGM distribution is not publicly available, but the overall CGM market is rapidly growing, presenting an opportunity for Adapthealth. Revenue figures for specific product lines are not disclosed by the company.
- Home Medical Equipment (HME): This category includes mobility equipment, respiratory equipment and others. Competitors include Invacare (IVC) and Permobil. Market share data for HME is fragmented across many small businesses.
Market Dynamics
Industry Overview
The home medical equipment market is driven by an aging population, increasing prevalence of chronic diseases (like sleep apnea and diabetes), and a shift towards home-based healthcare. Technological advancements, such as remote patient monitoring, are also shaping the industry.
Positioning
Adapthealth Corp. is positioned as a leading provider of DME and related services, focused on chronic disease management. Its competitive advantages include its scale, distribution network, and relationships with healthcare providers and payers.
Total Addressable Market (TAM)
The total addressable market for durable medical equipment is estimated to be over $60 billion, growing in the mid-single digits annually. Adapthealth is well-positioned to capture a growing share of this market due to its focus on chronic disease management and its established distribution network.
Upturn SWOT Analysis
Strengths
- Large scale and established distribution network
- Strong relationships with healthcare providers and payers
- Focus on chronic disease management
- Recurring revenue stream from resupply programs
Weaknesses
- Reliance on acquisitions for growth
- Exposure to reimbursement risks from government and private payers
- High debt levels
- Integration risks associated with acquired companies
Opportunities
- Further expansion of chronic disease management offerings
- Increased adoption of remote patient monitoring technologies
- Growth in the aging population and prevalence of chronic diseases
- Potential for strategic acquisitions
Threats
- Changes in reimbursement policies
- Increased competition from other DME providers
- Product recalls or safety concerns
- Economic downturn impacting consumer spending on healthcare
Competitors and Market Share
Key Competitors
- ResMed (RMD)
- Dexcom (DXCM)
- Invacare (IVC)
- Abbott (ABT)
Competitive Landscape
Adapthealth's competitive advantage lies in its scale and established distribution network. However, it faces competition from larger, more diversified healthcare companies and smaller, more specialized DME providers.
Major Acquisitions
Patient Care Medical
- Year: 2021
- Acquisition Price (USD millions): 195
- Strategic Rationale: Expanded presence in diabetes and respiratory care. Diversified geographical footprint.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven primarily by acquisitions, supplemented by organic growth in existing business lines.
Future Projections: Future growth is expected to be driven by continued acquisitions, expansion of chronic disease management offerings, and increased adoption of remote patient monitoring. Analyst estimates vary.
Recent Initiatives: Recent initiatives include acquisitions of companies in the sleep therapy and diabetes care spaces, as well as investments in technology to improve patient engagement and streamline operations.
Summary
Adapthealth Corp is a key player in the DME market, especially in chronic disease management, boosted by strategic acquisitions and a strong distribution network. Its growth depends on effectively integrating new businesses and navigating reimbursement challenges. While the company benefits from a growing market, it carries debt and faces competitive pressures from established players. The company should prioritize profitability and efficient capital allocation to enhance long-term shareholder value.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Filings (SEC)
- Industry Reports
- Analyst Estimates
- Company Website
Disclaimers:
The information provided is for informational purposes only and does not constitute financial advice. Market data and market share are estimations. Financial data needs to be verified against the most current information.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Adapthealth Corp
Exchange NASDAQ | Headquaters Plymouth Meeting, PA, United States | ||
IPO Launch date 2018-05-24 | CEO & Director Ms. Suzanne M. Foster M.P.H. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 10500 | Website https://adapthealth.com |
Full time employees 10500 | Website https://adapthealth.com | ||
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.